About Toronto Immune & Digestive Health Institute Inc.
"Endoscopy and colonoscopy services with full sedation; medication infusions; gastroenterology and general surgery consultations; digestive health nutrition and mental health services. Open on some weekend dates by appointment. Please confirm at least 3 days prior to your appointment to be sure we are open. All of our staff are fully vaccinated for COVID-19 as a requirement of employment. We offer NAAT rapid COVID-19 tests on site to maximize safety in our modern, spacious and well ventilated space."
Clinical Trials at Toronto Immune & Digestive Health Institute Inc.
During the past decade, Toronto Immune & Digestive Health Institute Inc. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Toronto Immune & Digestive Health Institute Inc."
#1 collaborator was "Gilead Sciences" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Toronto Immune & Digestive Health Institute Inc.
According to Clinical.Site data, the most researched conditions in "Toronto Immune & Digestive Health Institute Inc." are
"Crohn's Disease" (2 trials), "Colitis, Ulcerative" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Toronto Immune & Digestive Health Institute Inc." in a lesser frequency.
Clinical Trials Intervention Types at Toronto Immune & Digestive Health Institute Inc.
Most popular intervention types in "Toronto Immune & Digestive Health Institute Inc." are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Filgotinib" (2 trials), "Guselkumab" (2 trials), "Golimumab" (1 trials) and "JNJ-78934804" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Toronto Immune & Digestive Health Institute Inc.
The vast majority of trials in "Toronto Immune & Digestive Health Institute Inc." are
4 trials for "All" genders.
Clinical Trials Status at Toronto Immune & Digestive Health Institute Inc.
Currently, there are NaN active trials in "Toronto Immune & Digestive Health Institute Inc.".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 1 completed trials in Toronto Immune & Digestive Health Institute Inc.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Toronto Immune & Digestive Health Institute Inc., 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".